REIMBURSEMENT ACCESS FOUNDATION & ADJUDICATION
Dead · Refused DEAD/APPLICATION/Refused/Dismissed or Invalidated
What this record means
The record shows that the mark REIMBURSEMENT ACCESS FOUNDATION & ADJUDICATION was filed by Bristol‑Myers Squibb Company on Jan 17 2018, but it was abandoned on Nov 17 2018 after the applicant failed to respond to an Office action, so the application is dead and never entered the register. The goods and services listed are analytical software that uses an electronic record infrastructure—including a patient’s medical information and treatment history—to determine value‑based drug prices agreed between payers and pharmaceutical companies (Class 009), and a business method that uses the same electronic record infrastructure for that pricing purpose (Class 042). A similar name used in connection with software or pricing services for health‑care data would raise the closest record‑based concern, while uses in unrelated fields would be farther from the scope shown. The prosecution history contains only the non‑final action and the abandonment notices; no oppositions, cancellations or court actions appear, so the supplied history shows no enforcement activity. I'd treat this as a meaningful concern if you plan to brand a health‑data pricing platform with a comparable name.
Informational only - not legal advice.Mark Trademark, Service Mark
| Drawing type | 4 - STANDARD CHARACTER MARK |
| Filing basis | Intent-to-Use (§1(b)). |
| Status | Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page. |
Key dates
| Application filed | Jan 17, 2018 |
| Status date | Nov 17, 2018 |
Goods & services
Analytical software that uses an electronic record infrastructure including a patient's medical information and treatment history to determine value-based drug prices agreed upon between payers and pharmaceutical companies
Business method to use an electronic record infrastructure including a patient's medical information and treatment history to determine value-based drug prices agreed upon between payers and pharmaceutical companies
Owner & representation
| Owner | Bristol-Myers Squibb Company |
| Address | 430 E. 29th Street, 14th Floor, New York, NEW YORK UNITED STATES 10016 |
| Entity | CORPORATION - organized in DELAWARE |
| Attorney of record | Xiomara Triana |
| Correspondent | XIOMARA TRIANA |
| Attorney email | u********@*****.com |
| Correspondent email | u********@*****.com |
| Correspondent address | PRINCETON, NEW |